CytoDyn Inc. (CYDY) Set to Host Conference Call on January 5, 2017
In a news release issued late Tuesday, CytoDyn Inc. (OTCQB: CYDY), a biotechnology company focused on the development of new antibody therapies for combatting human immunodeficiency virus (HIV) infection, announced that its management team will be hosting an investment community conference call on Thursday, January 5, 2017, at 4:00 pm EST. The call is expected to feature an update on developments related to CytoDyn’s clinical and regulatory programs. The company will also be posting to its website (www.CytoDyn.com) a “Letter to Shareholders and Friends” from Nader Pourhassan Ph.D., president and CEO of CytoDyn. This letter, which will also be made…